Fill L, Rowane M, Graven K, Sanan N, Wu S, Hostoffer R
Allergy Rhinol (Providence). 2020; 11:2152656720915701.
PMID: 32284906
PMC: 7133068.
DOI: 10.1177/2152656720915701.
Othus M, Barlogie B, LeBlanc M, Crowley J
Clin Cancer Res. 2012; 18(14):3731-6.
PMID: 22675175
PMC: 3744099.
DOI: 10.1158/1078-0432.CCR-11-2859.
Thirukkumaran C, Morris D
Bone Marrow Res. 2011; 2011:632948.
PMID: 22046569
PMC: 3199974.
DOI: 10.1155/2011/632948.
Shim B, Lee M, Byun J, Roh S, Song C, Park J
Korean J Intern Med. 2004; 19(2):114-20.
PMID: 15366643
PMC: 4531588.
DOI: 10.3904/kjim.2004.19.2.114.
Brice P, Godin S, LIBERT O, Marolleau J, Makki J, Extra J
Pharmacoeconomics. 1995; 7(3):238-41.
PMID: 10155313
DOI: 10.2165/00019053-199507030-00007.
Frozen vs. nonfrozen bone marrow for autologous transplantation in lymphomas: a report from the Spanish GEL/TAMO Cooperative Group.
Sierra J, Conde E, Iriondo A, Brunet S, Marin J, Perez de Oteiza J
Ann Hematol. 1993; 67(3):111-4.
PMID: 8373895
DOI: 10.1007/BF01701731.
Improvement of hematologic recovery after high-dose intensification using peripheral blood progenitor cells (PBPC) mobilized by chemotherapy and GM-CSF.
Lamy T, Drenou B, Grulois I, Leberre C, Dauriac C, Amiot L
Ann Hematol. 1994; 69(6):297-302.
PMID: 7993937
DOI: 10.1007/BF01696558.
Autologous bone marrow transplantation for intra-abdominal extramedullary plasmacytoma.
Velders G, Fibbe W, Kluin P, Bieger R
Ann Hematol. 1994; 69(5):261-4.
PMID: 7948316
DOI: 10.1007/BF01700281.
The role of autografting in lymphoma.
Milligan D, Long S
Postgrad Med J. 1994; 70(825):475-8.
PMID: 7937424
PMC: 2397661.
DOI: 10.1136/pgmj.70.825.475.
Infusions of interleukin-1 alpha after autologous transplantation for Hodgkin's disease and non-Hodgkin's lymphoma induce effector cells with antilymphoma cytolytic activity.
Katsanis E, Weisdorf D, Xu Z, Dancisak B, Halet M, Blazar B
J Clin Immunol. 1994; 14(3):205-11.
PMID: 7929695
DOI: 10.1007/BF01533369.
Relationships between ablation of distinct haematopoietic cell subsets and the development of donor bone marrow engraftment following recipient pretreatment with different alkylating drugs.
Down J, Boudewijn A, Dillingh J, Fox B, Ploemacher R
Br J Cancer. 1994; 70(4):611-6.
PMID: 7917905
PMC: 2033390.
DOI: 10.1038/bjc.1994.359.
Autotransplants with peripheral blood stem cells and clinical results obtained in children: a review.
Leibundgut K, Hirt A, Luthy A, Tobler A, Wagner H
Eur J Pediatr. 1993; 152(7):546-54.
PMID: 7689055
DOI: 10.1007/BF01954078.
Refractory and relapsing Hodgkin's disease: role of high-dose chemotherapy with bone marrow transplantation.
Thomas M, Gattermann N, Schneider W
Klin Wochenschr. 1990; 68(11):539-44.
PMID: 2198377
DOI: 10.1007/BF01667145.
Dose intensity in cancer chemotherapy.
Dodwell D, Gurney H, Thatcher N
Br J Cancer. 1990; 61(6):789-94.
PMID: 2164831
PMC: 1971684.
DOI: 10.1038/bjc.1990.178.
Intensive chemotherapy for adult lymphoblastic lymphomas.
Liang R, Todd D, Chan T, Chiu E, Lie A, Ho F
Cancer Chemother Pharmacol. 1991; 29(1):80-2.
PMID: 1720710
DOI: 10.1007/BF00686341.
Granulocyte-macrophage colony-stimulating factor (GM-CSF): what role in bone marrow transplantation?.
Schuster M
Infection. 1992; 20 Suppl 2:S95-9.
PMID: 1493941
DOI: 10.1007/BF01705025.
